Item 8.01 Other Events

On August 12, 2022, Seagen Inc. issued a press release regarding the outcome of the arbitration with Daiichi Sankyo Co. Ltd. relating to the parties' 2008 collaboration agreement for the use of Seagen's antibody-drug conjugate technology. The press release is attached as Exhibit 99.1 to this current report and is incorporated by reference herein.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits



99.1     Press Release of Seagen Inc. dated August 12, 2022

104    Cover Page Interactive Data File (formatted in Inline XBRL)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses